pCDNA3-HA-HA-human CMYC (1-357)
(Plasmid
#203429)
-
PurposeMammalian expression of MYC
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 203429 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3
-
Backbone manufacturerInvitrogen
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameMYC
-
SpeciesH. sapiens (human)
-
Entrez GeneMYC (a.k.a. MRTL, MYCC, bHLHe39, c-Myc)
-
Tag
/ Fusion Protein
- 2 x HA (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Unknown (unknown if destroyed)
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGHrev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCDNA3-HA-HA-human CMYC (1-357) was a gift from Yoshiaki Ito (Addgene plasmid # 203429 ; http://n2t.net/addgene:203429 ; RRID:Addgene_203429) -
For your References section:
RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3beta-FBXW7 cascade. Oei V, Chuang LSH, Matsuo J, Srivastava S, Teh M, Ito Y. Commun Biol. 2023 Jul 3;6(1):689. doi: 10.1038/s42003-023-05037-0. 10.1038/s42003-023-05037-0 PubMed 37400551